ALNA

Allena Pharmaceuticals, Inc. ALNA

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ALNA CHRO TNFA TVRD IMVIF APGN OMGA EPIX TSBX CRVO
6M -38.12 % -94.23 % -72.92 % -85.17 % -90.00 % -38.57 % -88.68 % -88.02 % -1.31 % 24.34 %
YTD 0.00 % -81.33 % -95.48 % -17.96 % -90.00 % -40.75 % -81.77 % -89.01 % -33.95 % 280.27 %
1Y -81.39 % -87.38 % -97.08 % -17.96 % -90.00 % -93.88 % -95.79 % -89.18 % -46.69 % 253.33 %
3Y -96.79 % -97.19 % -97.28 % -17.96 % -100.00 % -96.38 % -97.81 % -94.05 % -96.77 % 3.29 %
5Y -98.85 % -97.19 % -97.28 % -17.96 % -100.00 % -96.38 % -99.11 % -96.83 % -96.77 % -85.69 %
10Y -99.25 % -97.19 % -97.28 % -17.96 % -100.00 % -96.38 % -99.11 % -99.80 % -96.77 % -99.99 %
From the beginning -99.25 % -97.19 % -97.28 % -17.96 % -100.00 % -96.38 % -99.11 % -99.77 % -96.77 % -100.00 %

Dividend

ESSA Pharma Inc.